Physician profile
Ryan D Miller
NPI 1134383649
$5,330.12
in general payments reported to CMS, 2019-2025
27 companies · $436 in 2025
The $436 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $206 · 2021: $3,403 · 2022: $306 · 2023: $276 · 2024: $391 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Education: $69.99 · Travel and Lodging: $12.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.79 |
| Education | $69.99 |
| Travel and Lodging | $12.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,022.53 | 2021-2023 | Da Vinci Surgical System |
| Abbvie INC. | $747.46 | 2019-2025 | |
| Astellas Pharma US INC | $265.72 | 2023-2025 | Veozah |
| Organon LLC | $204.48 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $133.13 | 2021-2025 | Slynd |
| Biogen, INC. | $127.67 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $114.53 | 2020-2023 | Injectafer |
| Coopersurgical, INC. | $105.46 | 2019-2025 | Paragard T 380a |
| Boston Scientific Corporation | $91.46 | 2019-2024 | Obtryx System - Curved |
| Bayer Healthcare Pharmaceuticals INC. | $84.84 | 2019-2022 | |
| Hologic Sales and Service, LLC | $74.62 | 2021-2025 | Novasure |
| Pfizer INC. | $65.70 | 2022-2025 | |
| Shield Therapeutics INC | $50.07 | 2024-2025 | |
| Therapeuticsmd, INC. | $38.39 | 2020-2021 | |
| Dexcom, INC. | $33.22 | 2025 | Dexcom G6 Transmitter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $30.94 | 2025 | Irrisept |
| Axonics, INC. | $17.76 | 2022 | |
| Teleflex LLC | $16.12 | 2019 | |
| Channel Medsystems, INC. | $14.57 | 2023 | |
| Merck Sharp & Dohme LLC | $14.51 | 2019 | |
| Becton, Dickinson and Company | $13.72 | 2019 | |
| Meditrina | $13.55 | 2025 | |
| Dynavax Technologies Corporation | $12.67 | 2022 | |
| Allergan, INC. | $11.79 | 2019 | |
| Myovant Sciences INC. | $11.37 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.28 | 2020 | |
| Mayne Pharma Commercial LLC | $2.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.